Related Experiment Video
Updated: Jul 15, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy
Jake B Guinto1, Gillian P Ritson, J Paul Taylor
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 422 Curie Blvd., 605B Stellar-Chance Building, Philadelphia, PA, 19104-6140, USA.
Abstract:
Frontotemporal dementia with inclusion body myopathy and Paget's disease of bone (IBMPFD) is a rare, autosomal dominant disorder caused by mutations in the gene valosin-containing protein (VCP). The CNS pathology is characterized by a novel pattern of ubiquitin pathology distinct from sporadic and familial frontotemporal lobar degeneration with ubiquitin-positive inclusions without VCP mutations. Yet, the ubiquitin-positive inclusions in IBMPFD also stain for TAR DNA binding protein, a feature that links this rare disease with the pathology associated with the majority of sporadic FTD as well as disease resulting from different genetic alterations. VCP, a member of the AAA-ATPase gene family, associates with a plethora of protein adaptors to perform a variety of cellular processes including Golgi assembly/disassembly and regulation of the ubiquitin-proteasome system. However, the mechanism whereby mutations in VCP lead to CNS, muscle, and bone disease is largely unknown. In this report, we review current literature on IBMPFD, focusing on the pathology of the disease and the biology of VCP with respect to IBMPFD.
Insights
Frontotemporal dementia with inclusion body myopathy and Paget's disease of bone (IBMPFD), caused by VCP gene mutations, presents unique brain pathology. This review explores IBMPFD's distinct ubiquitin inclusions and VCP protein's role in cellular functions.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Frontotemporal dementia with inclusion body myopathy and Paget's disease of bone (IBMPFD) is a rare autosomal dominant disorder.
- Mutations in the valosin-containing protein (VCP) gene are the known cause of IBMPFD.
- The disease affects the central nervous system (CNS), muscles, and bones.
Purpose of the Study:
- To review the current literature on IBMPFD.
- To focus on the pathology of the disease, particularly CNS involvement.
- To explore the biology of the VCP gene and its relation to IBMPFD.
Main Methods:
- Literature review of existing studies on IBMPFD.
- Analysis of CNS pathology, including ubiquitin and TAR DNA binding protein staining.
- Examination of VCP protein's cellular functions and involvement in IBMPFD.
Main Results:
- IBMPFD exhibits a unique pattern of ubiquitin pathology in the CNS.
- These ubiquitin inclusions also stain positive for TAR DNA binding protein.
- This finding links IBMPFD pathology to other forms of frontotemporal lobar degeneration (FTLD).
Conclusions:
- VCP mutations lead to a distinct neuropathology in IBMPFD.
- Understanding VCP's role in cellular processes is crucial for elucidating disease mechanisms.
- Further research is needed to fully understand how VCP mutations cause multi-system disease.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Lysosomal Hydrolases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Parkinson Disease ll: Pathophysiology

